We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$378M
AUM Growth
+$22.7M
Cap. Flow
-$2.63M
Cap. Flow %
-0.7%
Top 10 Hldgs %
31.74%
Holding
97
New
18
Increased
35
Reduced
31
Closed
13

Top Buys

Rank Stock Value
1
MASI
Masimo
MASI
+$7.85M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$5.39M
3
IMUX icon
Immunic
IMUX
+$4.26M
4
ETNB
89bio
ETNB
+$3.49M
5
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
+$3.31M

Top Sells

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$8.03M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$6.37M
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$4.89M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$3.45M
5
NVAX icon
Novavax
NVAX
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 92.08%
2 Technology 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$18.4M 4.87%
236,954
-24,952
-10% -$1.72M
DHR icon
2
Danaher
DHR
$144B
$14M 3.71%
73,329
+16,929
+30% +$3.01M
NBIX icon
3
Neurocrine Biosciences
NBIX
$16.6B
$12.7M 3.37%
132,544
+11,018
+9% +$1.27M
NTRA icon
4
Natera
NTRA
$46.4B
$12.7M 3.35%
175,161
+25,028
+17% +$1.42M
DXCM icon
5
DexCom
DXCM
$32B
$12.2M 3.23%
118,276
-11,964
-9% -$1.25M
HUM icon
6
Humana
HUM
$46.2B
$11M 2.91%
26,509
-3,491
-12% -$1.4M
MRK icon
7
Merck
MRK
$318B
$10.4M 2.76%
131,874
+8
+0% +$627
EW icon
8
Edwards Lifesciences
EW
$51.7B
$9.78M 2.59%
122,531
+2,531
+2% +$197K
TPTX
9
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.64M 2.55%
110,335
+17
+0% +$1.18K
CRL icon
10
Charles River Laboratories
CRL
$12.8B
$9.06M 2.4%
40,005
+5
+0% +$1.04K
AXNX
11
DELISTED
Axonics, Inc. Common Stock
AXNX
$9.03M 2.39%
176,950
-64,959
-27% -$2.71M
VCEL icon
12
Vericel Corp
VCEL
$2.31B
$8.35M 2.21%
450,400
-24,896
-5% -$412K
IQV icon
13
IQVIA
IQV
$39.3B
$8.28M 2.19%
52,508
+5,008
+11% +$785K
MASI
14
DELISTED
Masimo
MASI
$8.26M 2.19%
+35,000
New +$7.85M
SILK
15
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$8.07M 2.14%
120,015
+15
+0% +$819
CTLT
16
DELISTED
CATALENT, INC.
CTLT
$7.71M 2.04%
90,016
-4,984
-5% -$421K
PODD icon
17
Insulet
PODD
$9.79B
$7.69M 2.04%
32,503
+15,003
+86% +$3.16M
IMUX icon
18
Immunic
IMUX
$195M
$7.43M 1.97%
40,002
+26,002
+186% +$4.26M
GNMK
19
DELISTED
GenMark Diagnostics, Inc
GNMK
$6.82M 1.81%
480,199
-319,801
-40% -$4.89M
ABBV icon
20
AbbVie
ABBV
$435B
$6.57M 1.74%
75,008
+8
+0% +$753
UNH icon
21
UnitedHealth
UNH
$370B
$6.55M 1.73%
21,001
-7,499
-26% -$2.3M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$126B
$6.12M 1.62%
22,501
+2,501
+13% +$690K
DRNA
23
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5.86M 1.55%
325,863
+25,058
+8% +$519K
ITMR
24
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$5.74M 1.52%
280,700
+50
+0% +$1.12K
ALXN
25
DELISTED
Alexion Pharmaceuticals
ALXN
$5.72M 1.52%
+50,000
New +$5.39M
1
2 3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Parkman Healthcare Partners held 97 positions worth $378M, up 6.4% from $355M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parkman Healthcare Partners's Q3 2020 filing shows 18 new, 35 increased, 31 reduced and 13 closed positions. Its largest new stake was Masimo: 35,000 shares worth $8.26M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $8.03M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 90% a quarter earlier, followed by Technology.

  • Parkman Healthcare Partners's largest Q3 2020 buy was Masimo: 35,000 shares worth $8.26M.
  • Parkman Healthcare Partners added most to Immunic in Q3 2020, an estimated $4.26M increase.
  • Parkman Healthcare Partners's biggest Q3 2020 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $8.03M.
  • Parkman Healthcare Partners fully exited Seagen Inc. Common Stock in Q3 2020, selling an estimated $6.37M.
  • Parkman Healthcare Partners's ten largest holdings make up 32% of its $378M portfolio in Q3 2020.
  • Parkman Healthcare Partners opened 18 new positions and closed 13 in Q3 2020.
  • Parkman Healthcare Partners's portfolio value rose 6.4% quarter-over-quarter to $378M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2020, filed 13 Nov 2020.